No insider purchase over the last 90 days. The latest was filed 01 Apr 2021.
Attana AB is a Health Care company. Its directors and officers file their transactions with Finansinspektionen. 1 insider has disclosed 1 filing since 18 October 2025.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
With 1 filing in twelve months, the company is quieter than the median of 7 filings across the 886 companies we follow on the same exchange. Our records for Attana AB go back to 2021, with 1 purchase and 4 sales on the open market in total.
Over the last twelve months, not one insider purchase of Attana AB stock was filed.
For comparison within the same sector, see the insider buying recorded at MAIA Biotechnology, Inc. and Cooper Companies, Inc. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.
· cache
6 of 6 declarations
Attana AB is a company focused on developing diagnostic and research technologies in the healthcare and pharmaceutical sector. It is listed on the XSTO exchange.